Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: A meta-analysis of randomized controlled trials
Authors:
- 3 June 2015
- journal article
- review article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 10 (2) , 816-822
Abstract
The aim of the present study was to compare the health outcomes of catheter ablation therapy against those of antiarrhythmic drugs (AADs) in the management of atrial fibrillation (AF). The effects of catheter ablation and AADs on a number of parameters were compared, including AF recurrence, all‑cause mortality, stroke/transient ischemic attack (TIA) and quality of life (QoL). A systematic literature search of PubMed, Embase and the Cochrane Central Register of Controlled Trials was conducted to obtain relevant randomized controlled trials. The relative risks (RRs) and 95% confidence intervals (CIs) of AF recurrence, all‑cause mortality and stroke/TIA between catheter ablation and AADs were subsequently calculated. Weighted mean differences (WMDs) and 95% CIs were used to evaluate the QoL between the two therapy groups. In total, 11 randomized trials, which included 1,763 AF patients, were eligible for the meta‑analysis. Overall, the results indicated that catheter ablation produces superior outcomes compared with AADs in reducing AF recurrence (RR, 0.47; 95% CI, 0.38‑0.58; P<0.001) and improving the QoL (physical component summary: WMD, 2.23; 95% CI, 0.24‑4.21; P=0.03; mental component summary: WMD, 2.69; 95% CI, 0.04‑5.35; P=0.05). However, no statistically significant difference was identified between the two groups with regard to the incidence of all‑cause mortality (RR, 0.87; 95% CI, 0.37‑2.06; P=0.76) and stroke/TIA (RR, 1.83; 95% CI, 0.73‑4.55; P=0.20). In summary, catheter ablation was demonstrated to markedly reduce AF recurrence and improve QoL when compared with AAD therapy. However, the incidence rates of all‑cause mortality and stroke/TIA were comparable between catheter ablation and AAD therapy.Keywords
This publication has 30 references indexed in Scilit:
- Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patientsEP Europace, 2012
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEuropean Heart Journal, 2012
- Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007Circulation: Cardiovascular Quality and Outcomes, 2012
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial FlutterCanadian Journal of Cardiology, 2011
- 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)Circulation, 2011
- Increasing Prevalence of Atrial Fibrillation and Flutter in the United StatesThe American Journal of Cardiology, 2009
- An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland ChinaJournal of Epidemiology, 2008
- Circumferential Pulmonary-Vein Ablation for Chronic Atrial FibrillationNew England Journal of Medicine, 2006
- Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial FibrillationJAMA, 2005
- Impact of Atrial Fibrillation on the Risk of DeathCirculation, 1998